gilberto lopes ✓

@GlopesMd · Miami, FL · joined 16 Nov 2013

Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief emeritus JCO GO, Board Member @UICC - chair #ATOMcoalition

37 564Followers

40 000Following

57 608Posts total

10.7KViews on collected posts

Postingan terbaru

gilberto lopes ✓@GlopesMd8 Sep

Visual summary of today’s phase 3 DeLLphi-305 update in ES-SCLC: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after induction durvalumab + platinum/etoposide. PFS and ORR also positive. Full data still needed. #SCLC #LCSM https://t.co/pyeQbPyoRc

1K views · 15 likes · 7 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

1/3 Big news in #SCLC today. Phase III DeLLphi-305: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after first-line platinum/etoposide + durvalumab in ES-SCLC. PFS and ORR also positive. Very encouraging—full data will matter. 1K views · 13 likes · 3 reposts · 2 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

@iaslc #WCLC26 @oncoalert @oncodaily @larvol @tribeMDUS @sylvestercancer @oncbrothers @chinmay @Jani_Chinmay @latinamd @colazagasti @openmedicineHQ @asco @myesmo @openmedkate @openmedben @chadinabhan 760 views · 6 likes · 2 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

Seoul, Rebuilt: What a City and the World Conference on Lung Cancer Can Teach Us About Progress https://t.co/b6TNHeXEOV @IASLC #WCLC26 @uicc 1.8K views · 19 likes · 6 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd20 Aug

@GlopesMd @WSJopinion Really nice piece my friend 👌🏻👍🏻 31 views · 1 likes · 0 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

@GlopesMd @WSJopinion well said 172 views · 1 likes · 1 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

“Americans grew richer in the goods that markets could freely supply, and poorer in the three purchases that define middle-class standing: a house, a degree and a doctor.” 2.5K views · 7 likes · 3 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd5 Aug

My piece @WSJopinion: Americans Got Wealthier but Don’t Feel Like It https://t.co/QiKHd2XY1Y https://t.co/HZNwsDLl8y

3.4K views · 8 likes · 3 reposts · 2 replies Open on X →

Dibandingkan akun berukuran sama

8 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. tepat di median untuk rentang pengikutnya.

Median tayangan1 025akun ini924median untuk 10K–100K

Jangkauan, %2.73%akun ini3.62%median untuk 10K–100K

Interaksi, %1.63%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	1 025	924	1.11×
Jangkauan (tayangan ÷ pengikut)	2.73%	3.62%	0.75×
Tingkat interaksi	1.63%	1.52%	1.07×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K5 Aug

2.5K6 Aug

172

3120 Aug

1.8K8 Sep

760

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%5 Aug

0.41%6 Aug

1.74%

3.23%20 Aug

1.51%8 Sep

1.05%

1.77%

2.22%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes63.1%70 in total

Reposts22.5%25 in total

Replies6.3%7 in total

Quotes1.8%2 in total

Bookmarks6.3%7 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Postingan terbaru

Dibandingkan akun berukuran sama

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Akun serupa